Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers

Abstract

Resting EEG and ¹²³ I-FP-CIT-SPECT are good predictors of future cognitive worsening, in de novo drug-naive PD patients. Wherever available, these biomarkers could add valuable prognostic information to classification into different clinical phenotypes. © 2017 International Parkinson and Movement Disorder Society.